Search
Close this search box.

Vaccine Manufacturing PROGRAM

The Vaccine Manufacturing Program accelerates the implementation of new manufacturing technologies across a variety of platform processes.
Categories
Vaccines

Solution

The Vaccine Manufacturing Program accelerates the implementation of new manufacturing technologies across a variety of platform processes. It brings together stakeholders and resources to collaboratively identify opportunities to advance manufacturing related issues relevant to the development and distribution of vaccines. These efforts include the establishment of the NIIMBL Center of Excellence for Vaccine Analytics and Assays that supports manufacturing and product characterization of vaccines. The activities of the Program address the technology and workforce needs of major vaccine companies and suppliers in the U.S. while serving the interests of the global community through additional support from the Bill and Melinda Gates Foundation.

Click here for a more detailed overview of the Vaccine Manufacturing Program.

Updates, Related Publications, and Deliverables

  • Login to the NIIMBL member portal for access to project updates, related publications, and deliverables. 

Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.

Project Lead

NIIMBL

NIIMBL

Participating Organizations

AstraZeneca

AstraZeneca

Cytiva

Cytiva

Genentech

Genentech

MilliporeSigma/EMD Serono

MilliporeSigma/EMD Serono

Pfizer, Inc.

Pfizer, Inc.